{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:31Z","timestamp":1761540631744,"version":"3.44.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1053\/j.seminhematol.2004.10.001","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T14:42:06Z","timestamp":1115908926000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Treatment of von Willebrand disease"],"prefix":"10.1053","volume":"42","author":[{"given":"Francesco","family":"Rodeghiero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2004.10.001_bib1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2516.2002.00611.x","article-title":"von Willebrand disease","volume":"8","author":"Rodeghiero","year":"2002","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand\u2019s disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib4","first-page":"257","article-title":"Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation","volume":"14","author":"Ruggeri","year":"2001","journal-title":"Clin Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1963.tb05458.x","article-title":"The treatment of haemorrhage in von Willebrand\u2019s disease and the blood levels of factor VIII (AHG)","volume":"9","author":"Biggs","year":"1963","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0002-9343(68)90070-3","article-title":"Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand\u2019s disease (report of thirty-seven patients)","volume":"45","author":"Larrieu","year":"1968","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(76)90751-8","article-title":"Failure of AHF concentration to control bleeding in von Willebrand\u2019s disease","volume":"60","author":"Green","year":"1976","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib8","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1001\/jama.1976.03270250038023","article-title":"Antihemophilic factor concentrate therapy in von Willebrand\u2019s disease","volume":"236","author":"Blatt","year":"1976","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib9","first-page":"363","article-title":"The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, ATIII and OT in man","volume":"27","author":"Cash","year":"1974","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"A new pharmacological approach to the management of hemophilia and von Willebrand disease","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","article-title":"Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs","volume":"30","author":"Mannucci","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0268-960X(91)90032-8","article-title":"Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease","volume":"5","author":"Rodeghiero","year":"1991","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","article-title":"Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin","volume":"82","author":"Mannucci","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-114-7-563","article-title":"Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease","volume":"114","author":"Rose","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830310310","article-title":"Hyponatremia and seizures in young children given DDAVP","volume":"31","author":"Smith","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJM198801143180215","article-title":"Myocardial infarction in a patient with hemophilia A treated with DDAVP","volume":"318","author":"Bond","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830280115","article-title":"Thrombosis following desmopressin for uremic bleeding","volume":"28","author":"Byrnes","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease","volume":"66","author":"Mannucci","year":"1985","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0609.1988.tb00815.x","article-title":"Hyper-responsiveness to DDAVP for patients with type I von Willebrand\u2019s disease and normal intraplatelet von Willebrand factor","volume":"40","author":"Rodeghiero","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib22","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V67.2.465.465","article-title":"DDAVP in type IIa von Willebrand\u2019s disease","volume":"67","author":"Gralnick","year":"1986","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type II B von Willebrand disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2516.1996.tb00018.x","article-title":"Desmopressin and type II B von Willebrand disease","volume":"2","author":"Castaman","year":"1996","journal-title":"Hemophilia"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajh.2830430103","article-title":"Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand disease","volume":"43","author":"Castaman","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib27","first-page":"94","article-title":"Von Willebrand\u2019s disease in the year 2003","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2N (Normandy) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2141.1995.tb08921.x","article-title":"Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive von Willebrand disease","volume":"89","author":"Castaman","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib31","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP","volume":"59","author":"Ruggeri","year":"1982","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib32","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood.V74.6.1997.1997","article-title":"Consistency of responses to repeated DDAVP infusions in patients with von Willebrand\u2019s disease and hemophilia A","volume":"74","author":"Rodeghiero","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2165\/00003495-199550040-00003","article-title":"Current management of von Willebrand\u2019s disease","volume":"50","author":"Castaman","year":"1995","journal-title":"Drugs"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib34","first-page":"193","article-title":"Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease","volume":"62","author":"Rodeghiero","year":"1992","journal-title":"Vox Sang"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib35","first-page":"212","article-title":"Use of a high-purity factor VIII concentrate (Hemate P) in von Willebrand\u2019s disease","volume":"56","author":"Berntorp","year":"1989","journal-title":"Vox Sang"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib36","first-page":"173","article-title":"The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease","volume":"71","author":"Hanna","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib37","first-page":"304","article-title":"Haemate P in children with von Willebrand disease","volume":"24","author":"Kreuz","year":"1994","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1963.tb05457.x","article-title":"Transfusion studies in von Willebrand disease","volume":"9","author":"Cornu","year":"1963","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"High plasma concentration of facor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Ktraaijenhagen","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","article-title":"Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand\u2019s disease","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.1992.tb01159.x","article-title":"Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate","volume":"62","author":"Burnouf-Radosevich","year":"1992","journal-title":"Vox Sang"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00001721-199304060-00018","article-title":"Biological effects of a S\/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand disease","volume":"4","author":"Meriane","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with VWD with a VHP VWF concentrate","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"},{"issue":"suppl 3","key":"10.1053\/j.seminhematol.2004.10.001_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease","volume":"4","author":"Dobrkovska","year":"1998","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1612977","article-title":"Efficacy and safety of the factor VIII\/von Willebrand factor concentrate, Haemate-P\/Humate P:ristocetin cofactor unit dosing in patients with von Willebrand disease","volume":"87","author":"Lillicrap","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1351-8216.2003.00816.x","article-title":"Successful treatment of urgent bleeding in von Willebrand disease with factor VIII\/VWF concentrate (Humate-P)","volume":"9","author":"Gill","year":"2003","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1351-8216.2003.00809.x","article-title":"Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII\/VWF concentrate (Humate-P)","volume":"10","author":"Thompson","year":"2004","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Treatment of von Willebrand disease with a high purity factor VIII\/von Willebrand factor concentrate in the treatment of von Willebrand disease","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib52","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1182\/blood.V79.12.3130.bloodjournal79123130","article-title":"Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease","volume":"79","author":"Mannucci","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib53","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V83.10.3018.3018","article-title":"Proteolysis of von Willebrand factor in therapeutic plasma concentrates","volume":"83","author":"Mannucci","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib54","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V74.6.1972.1972","article-title":"DDAVP shortens the prolonged bleeding time of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor","volume":"74","author":"Cattaneo","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib55","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V77.9.1901.1901","article-title":"Hemostatic effect of normal platelet transfusion in severe von Willebrand disease","volume":"77","author":"Castillo","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/s-0038-1649813","article-title":"The reproductive health of women with von Willebrand disease unresponsive to DDAVP","volume":"74","author":"Foster","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib58","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2516.1998.440665.x","article-title":"Females with von Willebrand disease","volume":"4","author":"Kouides","year":"1998","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib59","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss\u2014A population study","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet Gynaecol Scand"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of menstrual blood loss","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0031-3955(16)34002-0","article-title":"Dysfunctional uterine bleeding in the adolescent","volume":"28","author":"Claessens","year":"1981","journal-title":"Pediatr Clin North Am"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<234::AID-AJH4>3.0.CO;2-Z","article-title":"On the value of menorrhagia as a predictor for coagulation disorders","volume":"53","author":"Edlund","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)08248-2","article-title":"Frequency of inherited bleeding disorders in women with menorrhagia","volume":"351","author":"Kadir","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/15246090152563551","article-title":"The prevalence of von Willebrand disease in women with abnormal uterine bleeding","volume":"10","author":"Goodman-Gruen","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib66","first-page":"282","article-title":"Pregnancy in women with different types of von Willebrand disease","volume":"68","author":"Conti","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"suppl 4","key":"10.1053\/j.seminhematol.2004.10.001_bib67","first-page":"28","article-title":"Women and inherited bleeding disorders","volume":"3","author":"Kadir","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0037-1614020","article-title":"Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F","volume":"84","author":"Castaman","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib69","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"Lak","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02919121","article-title":"Alloantibodies in congenital von Willebrand\u2019s disease","volume":"21","author":"Mannucci","year":"1991","journal-title":"Res Clin Lab"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V57.1.25.25","article-title":"Precipitating antibodies to FVIII\/von Willebrand factor in von Willebrand disease","volume":"57","author":"Mannucci","year":"1981","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib72","series-title":"Inhibitors to Coagulation Factors","first-page":"87","article-title":"Antibodies to von Willebrand factor in von Willebrand disease","author":"Mannucci","year":"1995"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0609.1987.tb01458.x","article-title":"Life-threatening reaction to FVIII concentrate in a patient with severe vWD and alloantibodies to von Willebrand Factor","volume":"39","author":"Mannucci","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib74","first-page":"348","article-title":"Posttransfusion anaphylactic reaction in a patient with severe von Willebrand disease","volume":"125","author":"Bergamaschini","year":"1995","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib76","unstructured":"Rodeghiero F, Castaman G: Epidemiology of von Willebrand disease, in Lee C, Kessler C (eds): Textbook of Hemophilia. (in press)"},{"key":"10.1053\/j.seminhematol.2004.10.001_bib77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/beha.2001.0136","article-title":"Congenital von Willebrand disease type 1","volume":"14","author":"Rodeghiero","year":"2001","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304002495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304002495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:15:44Z","timestamp":1758521744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196304002495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0037196304002495"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.10.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}